摘要
目的:分析对比治疗宫缩乏力性产后出血,分别采用马来酸麦角新碱、卡贝缩宫素、卡前列素氨丁三醇的效果及价值.方法:本研究时段介于2021年1月-2021年4月,对90例宫缩乏力性产后出血产妇予以选取,对其展开规范分组操作(每组30例);其中组1产妇臀部肌肉注射马来酸麦角新碱,组2产妇静脉推注卡贝缩宫素、组3产妇宫颈部注射卡前列素氨丁三醇;针对三组临床疗效、不良反应发生率、出血量、凝血功能以及生命体征、血红蛋白等观察指标加以对比.结果:(1)经对组2临床疗效展开评价,评价结果为96.66％,与组1(90.00％
Abstract
Objective To analyze and compare the effect and value of ergometrine maleate, cabesin and carboprost tromethamine in the treatment of postpartum hemorrhage caused by uterine atony.Methods: The study period was from January 2021 to April 2021.90 parturients with postpartum hemorrhage due to uterine atony were selected and divided into standard groups (30 in each group); In group 1, the gluteal muscles of the parturients were injected with ergometrine maleate, in group 2, the parturients were injected with cabesin intravenously, and in group 3, the cervix of the parturients were injected with carboprost tromethamine; The clinical efficacy, adverse reaction rate, bleeding volume, coagulation function, vital signs, hemoglobin and other observation indicators of the three groups were compared.Results: (1) After the evaluation of the clinical efficacy of group 2, the evaluation result was 96.66％.Compared with the evaluation results of group 1 (90.00％) and group 3 (73.33％), the clinical efficacy of group 2 was higher (P＜0.05).(2) The adverse reaction rate of group 2 was 3.33％, which was lower than that of group 1 (23.33％) and group 3 (6.66％) (P＜0.05).(3) After medication, the amount of bleeding in group 2 was evaluated.Compared with the other two groups, the amount of bleeding in group 2 was lower (P＜0.05).Conclusion: Compared with ergometrine maleate and carboprost tromethamine, carboprost oxytocin has a significant effect in the treatment of postpartum hemorrhage caused by uterine atony.It can improve the clinical efficacy and reduce the incidence of adverse reactions, and then reduce the amount of bleeding and improve the prognosis of parturients.
万方数据